214390 — Kyongbo Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Kyongbo Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4,290	6,348	4,477	4,138	7,228
Net Total Accounts Receivable
Net Total Receivables	47,909	50,799	56,858	52,311	66,625
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	111,166	116,326	135,902	151,941	159,138
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	95,677	93,919	96,073	99,852	128,023
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	236,979	240,545	266,305	283,887	319,538
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	88,814	95,569	118,261	132,660	147,249
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	91,278	96,841	121,924	137,733	173,800
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	145,701	143,704	144,381	146,154	145,738
Total Liabilities & Shareholders' Equity	236,979	240,545	266,305	283,887	319,538
Total Common Shares Outstanding